International Research Community for Tobacco and Nicotine Honors Roswell Park Leader

🔬 While this article celebrates a tobacco and nicotine researcher’s recognition by the international community, clinicians should note that cannabis and nicotine co-use is an increasingly documented pattern, particularly among adolescents and young adults, yet remains understudied in clinical settings. The scientific rigor applied to understanding nicotine dependence and harm reduction strategies in tobacco research offers a potential methodological template for investigating cannabis use patterns and their interaction with other substances, though direct translation assumes comparable pharmacology and behavioral mechanisms that may not hold. Providers should be aware that patients disclosing cannabis use may concurrently use nicotine products, and that standard tobacco cessation or dependence counseling may need adaptation to address polysubstance use patterns. Given the complexity of dual use and variable local regulatory landscapes around cannabis, clinicians are encouraged to maintain updated knowledge of co-use epidemiology and to screen for both substances independently during substance use assessment rather than assuming